ACAAI 2022: TCIs Safe for Use in Infants, Children, and Adults With Atopic Dermatitis
Systematic review reveals moderate-certainty evidence that the risk for cancer is no greater with use of topical calcineurin inhibitors.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.